Home » Posts tagged with » Boston Scientific
Boston Scientific to take full ownership of Preventice Solutions

Boston Scientific to take full ownership of Preventice Solutions

Boston Scientific, in late January 2021, signed an agreement to take full ownership of mobile cardiac health solutions and services provider Preventice Solutions in a deal that values 100% of the latter at up to $1.25 billion. The consideration includes $925 million in upfront cash payment and an additional payment of up to $300m based […]

Boston Scientific wraps up $4.2bn acquisition of BTG

Boston Scientific acquisition of BTG : US medical devices manufacturer Boston Scientific has wrapped up its previously announced $4.2 billion acquisition of UK-based healthcare company BTG. In November 2018, Boston Scientific reached an agreement on the terms of a recommended offer to acquire the British healthcare company for a cash consideration of 840 pence per […]

Continue reading …
Boston Scientific to be distributor of Endologix products in China

US medical devices company Endologix, which develops minimally invasive treatments for aortic disorders, signed an agreement with medical devices manufacturer Boston Scientific under which the latter becomes the exclusive distributor for its products in China. The long-term agreement covers distribution rights to Endologix’s EndoVascular Aneurysm Repair (EVAR) and Endovascular Aneurysm Sealing (EVAS) products, and also […]

Continue reading …
Boston Scientific to acquire spinal medical devices manufacturer Vertiflex

Boston Scientific acquisition of Vertiflex : US medical devices manufacturer Boston Scientific has agreed to acquire Vertiflex, a California-based manufacturer of spinal medical devices, for $465 million. Vertiflex has a minimally-invasive device called Superion Indirect Decompression System, which has been designed to enhance physical function and reduce pain in patients with lumbar spinal stenosis (LSS). […]

Continue reading …
Boston Scientific’s LUMINIZE RF Balloon Catheter meets objective in AF-FICIENT I trial

Boston Scientific said that its LUMINIZE Radiofrequency (RF) Balloon Catheter (LUMINIZE RF Balloon Catheter), which is intended to be used for isolating pulmonary veins during treatment of patients with atrial fibrillation (AF), has achieved positive safety and efficacy results in the AF-FICIENT I clinical trial. Atrial fibrillation patients are usually treated with anti-arrhythmic drugs and […]

Continue reading …